Need a specific person's email?
Browse Invitrocue's employee directory (about 26 employees) and reveal verified emails free.
Invitrocue's most common email format is First.Last@invitrocue.com (ex. John.Doe@invitrocue.com), used for 94% of invitrocue.com addresses. Invitrocue uses 2 email patterns.
| Format | Example | Share of invitrocue.com |
|---|---|---|
| First.Last@invitrocue.comMost common | John.Doe@invitrocue.com | |
| First_Last@invitrocue.com | John_Doe@invitrocue.com |
Browse Invitrocue's employee directory (about 26 employees) and reveal verified emails free.
Biotechnology ResearchKentucky, United States11-50 Employees
Invitrocue is a biotechnology research company focusing on 3D cell-based models, including patient-derived organoids from solid cancers. Its Onco-PDO platform supports in vitro drug screening on these organoids to inform personalized cancer treatment decisions. The firm aims to advance faster, more affordable disease therapies and to improve patient care. It is headquartered in Singapore with operations in Australia, China, Hong Kong and Germany, and it lists an address in Kentucky, United States; the company has 11-50 employees. In recent years, Invitrocue has pursued strategic partnerships and mergers, including a 2025 integration with Igenecast and a 2026 merger with Angsanalabs and Pathnova Laboratories, along with a 2026 collaboration with Averywell.
Most common format
First.Last@invitrocue.com
Example: John.Doe@invitrocue.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.